During the past decade, Pain Research of Oregon, LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pain Research of Oregon, LLC" #1 collaborator was "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pain Research of Oregon, LLC" are "Opioid-Induced Bowel Dysfunction" (2 trials), "Cancer Pain" (1 trials) and "Chronic Intractable Pain" (1 trials). Many other conditions were trialed in "Pain Research of Oregon, LLC" in a lesser frequency.

Most popular intervention types in "Pain Research of Oregon, LLC" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intraspinal Gabapentin" (1 trials), "Lubiprostone" (1 trials), "Lubiprostone 24" (1 trials), "NP2" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pain Research of Oregon, LLC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Pain Research of Oregon, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Pain Research of Oregon, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pain Research of Oregon, LLC, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".